Revenue $3.93B, up 5.0% on a year earlier. Diluted EPS $0.32 against $0.43.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $3.93B | $3.87B | $3.74B | +5.0% |
| Net income | $25.00M | $27.00M | $36.00M | -30.6% |
| Diluted EPS | $0.32 | $0.34 | $0.43 | |
| Operating cash flow | $205.00M | $81.00M | $172.00M | +19.2% |
| Capital expenditures | -$67.00M | -$73.00M | -$57.00M | |
| Free cash flow | $138.00M | $8.00M | $115.00M | +20.0% |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Net sales growth | 5.03% | 0.67% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Adient (ADNT) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/ADNT/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
